Delivery Order SPE2DB24D2018-SPE2DB25FWVT8
- Not listed
- The Defense Logistics Agency awarded a $1,242.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Lisdexamfetamine 50 mg capsules in quantities of 100. The contract is non-set-aside and competitively awarded, with an ultimate completion date of July 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order, which falls under the company's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,288.73 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 60 mg capsules (100 count) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $1,760.99 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 50 mg capsules (90-count). The contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100 count) with a ceiling value of $2,031.40. This is a firm fixed-price delivery order with no set-aside designation, reflecting AmerisourceBergen's capability to compete successfully in open federal procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Lisdexamfetamine 10 mg capsules (100 count) with a ceiling value of $1,501.54. This firm fixed-price delivery order, which must be completed by July 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carries no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,660.14 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100-count units). This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract represents a child order issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for Lisdexamfetamine 20 mg capsules (100-count units) with a ceiling value of $2,587.33. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The order is set to complete by July 25, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Lisdexamfetamine 50 mg capsules (100-count units) with a ceiling value of $4,014.49. The contract utilizes firm fixed pricing and requires completion by July 28, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This non-set-aside delivery order was competitively awarded and represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Lisdexamfetamine 60 mg capsules (100-count) with a ceiling value of $1,792.80. This firm fixed-price delivery order, with an ultimate completion date of July 24, 2025, represents a competitive award with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Lisdexamfetamine 50 mg capsules in a quantity of 90 units, with a ceiling value of $3,364.35. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and requires delivery by July 28, 2025, to Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order is a child contract under...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWVT8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,442.92 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 50 mg capsules (100 count) on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's distribution center in Conshohocken, Pennsylvania. This delivery order reflects routine pharmaceutical procurement through DLA's comprehensive medical supply chain, which leverages AmerisourceBergen's position as a major pharmaceutical distributor serving military and veteran healthcare systems. AmerisourceBergen's SPE2DX prime vendor contract enables the company to supply a broad range of pharmaceutical products and medical commodities to support Defense Health Agency operations and other federal healthcare systems globally. The lisdexamfetamine order exemplifies the routine, competitive pharmaceutical acquisitions that flow from this master contract vehicle, supporting military medical readiness and personnel healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/23/25 |